The study to be carried out in Vernier (GE) will investigate to what extent a regulated cannabis access programme can improve knowledge of cannabis use and associated problems, and reduce the health and social risks involved.
The open monocentre trial involves regulated, safe and responsible access to cannabis and is based on an association model. A point of sale (the so-called Cannabinothèque) will be established in the commune of Vernier, the principal partner of the ChanGE Association, which is responsible for conducting and overseeing this pilot trial.
The study to be carried out in Vernier (GE) will investigate to what extent a regulated cannabis access programme can improve knowledge of cannabis use and associated problems. Also to be investigated is whether participation in the trial has an impact on the amount of cannabis used and the choice of cannabis products. Lastly, it will also be studied whether participation in the trial has an impact on health and social factors.
Not-for-profit sales
Non-profit organisation point of sale
Institution responsible for carrying out the study
Association ChanGE
p.a. Mairie de Vernier
Rue du Village 9
Case postale 530
1214 Vernier (Genf)
Contact
Frau Ruth Dreifuss
ruth@dreifus.ch
Geneva
Vernier
from June 2023 to June 2027
Specialty store
Observational study
Planned total sample size: N = 1080
Privately funded by the ChanGE Association
Study website: www.changegeneve.ch
Last modification 18.07.2024
Contact
Federal Office of Public Health FOPH
Prevention of Non-Communicable Diseases Division
Schwarzenburgstrasse 157
3003
Bern
Switzerland
Tel.
+41 58 463 88 24